Stay updated on Pembrolizumab & Endocrine Therapy Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab & Endocrine Therapy Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab & Endocrine Therapy Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    Revision: v3.5.0 was added and Revision: v3.4.3 was removed.
    Difference
    0.0%
    Check dated 2026-03-20T19:50:46.000Z thumbnail image
  3. Check
    21 days ago
    No Change Detected
  4. Check
    28 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.4.3, replacing the previous Revision: v3.4.2.
    Difference
    0.0%
    Check dated 2026-03-06T17:11:01.000Z thumbnail image
  5. Check
    35 days ago
    Change Detected
    Summary
    Results posting details were added, including dates when results were first posted. The study documents were expanded with links to the protocol and informed consent forms, and the outcome measures were updated to specify RECIST-based endpoints and include multiple drug name synonyms.
    Difference
    5%
    Check dated 2026-02-27T13:09:53.000Z thumbnail image
  6. Check
    49 days ago
    Change Detected
    Summary
    The change is a minor version update (from v3.4.1 to v3.4.2) with no impact on study data, eligibility, or displayed content. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-13T01:24:54.000Z thumbnail image
  7. Check
    57 days ago
    Change Detected
    Summary
    The footer revision changed from v3.4.0 to v3.4.1; there is no change to core content such as study details, eligibility criteria, or trial results. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-05T12:17:02.000Z thumbnail image
  8. Check
    64 days ago
    Change Detected
    Summary
    The page now includes a 'Show glossary' option and displays 'Last Update Submitted that Met QC Criteria' along with 'No FEAR Act Data' and 'Revision: v3.4.0'. The previous labels 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and 'Revision: v3.3.4' were removed.
    Difference
    0.2%
    Check dated 2026-01-29T06:30:56.000Z thumbnail image

Stay in the know with updates to Pembrolizumab & Endocrine Therapy Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab & Endocrine Therapy Clinical Trial page.